{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:47:20Z","timestamp":1758055640163,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.chest.2022.01.043","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T05:06:59Z","timestamp":1654492019000},"page":"e355-e358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A 79-Year-Old Woman With Advanced Lung Carcinoma and Bilateral Infiltrates"],"prefix":"10.1016","volume":"161","author":[{"given":"Eline Cesilie","family":"Jager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wytze Sake","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Leslie","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Tomlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2022.01.043_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2022.01.043_bib2","doi-asserted-by":"crossref","unstructured":"Reungwetwattana T, Nakagawa K, Cho BC, et al. CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non\u2013small-cell lung cancer. J Clin Oncol. 2018;36(33):3290-3297.","DOI":"10.1200\/JCO.2018.78.3118"},{"issue":"1","key":"10.1016\/j.chest.2022.01.043_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jjco\/hyy179","article-title":"Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset","volume":"49","author":"Ohe","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.chest.2022.01.043_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/acr.2019.09.01","article-title":"Late-onset severe pneumonitis under osimertinib","volume":"3","author":"Syunyaeva","year":"2019","journal-title":"AME Case Rep"},{"issue":"1","key":"10.1016\/j.chest.2022.01.043_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.chest.2022.01.043_bib6","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.21037\/jtd-19-4000A","article-title":"Fatal toxic effects related to EGFR tyrosine kinase inhibitors based on 53 cohorts with 9,569 participants","volume":"12","author":"Xie","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"issue":"3","key":"10.1016\/j.chest.2022.01.043_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1148\/radiol.2021203427","article-title":"Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a\u00a0position paper from the Fleischner Society","volume":"298","author":"Johkoh","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.chest.2022.01.043_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12890-021-01539-x","article-title":"Osimertinib versus afatinib in patients with T790M-positive, non-small-cell lung cancer and multiple central nervous system metastases after failure of initial EGFR-TKI treatment","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.chest.2022.01.043_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211018028","article-title":"Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three Case studies","volume":"13","author":"Bickert","year":"2021","journal-title":"Ther Adv Med Oncol"},{"issue":"10299","key":"10.1016\/j.chest.2022.01.043_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222002100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222002100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:45:20Z","timestamp":1757925920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222002100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0012369222002100"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.01.043","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 79-Year-Old Woman With Advanced Lung Carcinoma and Bilateral Infiltrates","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}